Formulation and Drug Delivery, Other

European Commission Approves Lynparza for BRCA-Mutated Metastatic Pancreatic Cancer

July 08, 2020

The European Commission has approved Lynparza (olaparib) for use in patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer within the European Union.

Former 3M Drug Delivery Systems Launches as Kindeva Drug Delivery

May 04, 2020

Kindeva Drug Delivery plans capital investment and jobs growth.

N4 Pharma Develops Nanoparticle Technology for Vaccine Delivery

March 01, 2019

The technology uses a silica nanoparticle to deliver vaccines and cancer treatments.

Nanoform Invests in Nanoparticle Technology for Drug Development

September 19, 2018

The drug particle engineering and nanotechnology company offers a nanotechnology platform that can revive failed drugs in the pharma pipeline.

New Study Challenges Current Theories on Skin Delivery of Macromolecules

November 10, 2017

The authors of the study believe it could have significant implications for the discovery of new dermatological products for major diseases such as psoriasis.

Japanese Agency Supports Daiichi Sankyo’s Genetic Vaccine Platform

October 16, 2017

Through the support of the Japanese agency, Daiichi Sankyo intends to further develop its genetic vaccine platform focused around its new nucleic acid delivery technology.

PEGylation Reagents for Drug Delivery

October 11, 2017

Gelest, a manufacturer and provider of silane, silicone, and metal-organic compounds, released a range of dual-function poly(ethylene glycol) (PEG) reagents that enable new approaches to PEGylation for bioconjugates.

Formulation of Biologics for Non-Invasive Delivery

October 01, 2017

There is a lot of interest in delivering biologics via non-invasive routes in attempt to improve patient compliance and convenience.

New Project Seeks to Develop Novel Microfluidic Chip for Quick Formulation Stability Screening

June 07, 2017

The United Kingdom’s Center for Process Innovation (CPI) is investing in a new project, Microstar, which seeks to reduce risk for formulators through the development of accelerated screening methods for predictive design.

Duke Researchers Test PEG-Alternative as a New Drug Delivery Technology

December 06, 2016

Researchers test the efficacy of a new polymer that is an alternative to PEG for drugs used to treat type 2 diabetes.